1. Home
  2. HUBC vs PPCB Comparison

HUBC vs PPCB Comparison

Compare HUBC & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hub Cyber Security Ltd.

HUBC

Hub Cyber Security Ltd.

N/A

Current Price

$0.93

Market Cap

2.8M

Sector

N/A

ML Signal

N/A

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.17

Market Cap

3.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HUBC
PPCB
Founded
2017
2007
Country
Israel
Australia
Employees
322
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HUBC
PPCB
Price
$0.93
$0.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
327.3K
739.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$0.16
52 Week High
$5.09
$10.69

Technical Indicators

Market Signals
Indicator
HUBC
PPCB
Relative Strength Index (RSI) 35.50 29.68
Support Level $0.89 $0.16
Resistance Level $1.19 $0.40
Average True Range (ATR) 0.26 0.02
MACD -0.11 0.01
Stochastic Oscillator 2.87 7.48

Price Performance

Historical Comparison
HUBC
PPCB

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: